Evidence map›Paper›PMID 35807851›Full record

Trial reportNutrients2022

Dietary Protein Restriction Improves Metabolic Dysfunction in Patients with Metabolic Syndrome in a Randomized, Controlled Trial.

Rafael Ferraz-Bannitz, Rebeca A Beraldo, A Augusto Peluso, Morten Dall, Parizad Babaei, Rayana Cardoso Foglietti, Larissa Marfori Martins, Patricia Moreira Gomes, Julio Sergio Marchini, Vivian Marques Miguel Suen and 8 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Sixth Annual Symposium of the Midwest Aging Consortium.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 3 countries.

Rafael Ferraz-BannitzDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.ORCID 0000-0003-4496-4883
Rebeca A BeraldoDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.
A Augusto PelusoNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, DK-1350 Copenhagen, Denmark.ORCID 0000-0002-8653-2248
Morten DallNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, DK-1350 Copenhagen, Denmark.ORCID 0000-0002-8577-3162
Parizad BabaeiNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, DK-1350 Copenhagen, Denmark.
Rayana Cardoso FogliettiDepartment of Internal Medicine, Division of Nutrology, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.
Larissa Marfori MartinsDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.
Patricia Moreira GomesDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.ORCID 0000-0001-8532-0991
Julio Sergio MarchiniDepartment of Internal Medicine, Division of Nutrology, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.
Vivian Marques Miguel SuenDepartment of Internal Medicine, Division of Nutrology, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.
Luiz C Conti de FreitasDepartment of Ophthalmology, Otolaryngology, Head and Neck Surgery, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.ORCID 0000-0002-2153-6512
Luiz Carlos NavegantesDepartment of Physiology, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.
Marco Antônio M PrettiLaboratory of Bioinformatics and Computational Biology, Division of Experimental and Translational Research, Brazilian National Cancer Institute (INCA), Rio de Janeiro 20231-050, Brazil.ORCID 0000-0002-9511-294X
Mariana BoroniLaboratory of Bioinformatics and Computational Biology, Division of Experimental and Translational Research, Brazilian National Cancer Institute (INCA), Rio de Janeiro 20231-050, Brazil.ORCID 0000-0003-3495-9917
Jonas T TreebakNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, DK-1350 Copenhagen, Denmark.ORCID 0000-0003-1488-7012
Marcelo A MoriDepartment of Biochemistry and Tissue Biology, Obesity and Comorbidities Research Center (OCRC), Experimental Medicine Research Cluster, University of Campinas, Campinas 13083-970, Brazil.
Milton Cesar FossDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.
Maria Cristina Foss-FreitasDepartment of Internal Medicine, Division of Endocrinology and Metabolism, Ribeirao Preto Medical School, University of Sao Paulo (USP), Ribeirao Preto 14049-900, Brazil.ORCID 0000-0002-1350-1125
Universidade de São Paulo · BRUniversity of Copenhagen · DKInstituto Nacional de Câncer - INCA · BRUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

Innovation Fund Denmark 7043-00015BNovo Nordisk Foundation NNF17SA0031406Novo Nordisk Foundation NNF18CC0034900São Paulo Research Foundation (FAPESP) 2015/12133-0 and 2017/01184-9
6 · The paper itself

Abstract

Dietary restriction (DR) reduces adiposity and improves metabolism in patients with one or more symptoms of metabolic syndrome. Nonetheless, it remains elusive whether the benefits of DR in humans are mediated by calorie or nutrient restriction. This study was conducted to determine whether isocaloric dietary protein restriction is sufficient to confer the beneficial effects of dietary restriction in patients with metabolic syndrome. We performed a prospective, randomized controlled dietary intervention under constant nutritional and medical supervision. Twenty-one individuals diagnosed with metabolic syndrome were randomly assigned for caloric restriction (CR;

Indexed as

Metabolic SyndromeCaloric RestrictionDietary ProteinsDiet, Protein-RestrictedHumansObesityProspective StudiesDietary Proteinscaloric restrictioncardiovascular diseaseinsulin resistancemetabolic syndromeprotein restrictiontype 2 diabetes

Identifiers

PMID35807851
PMCPMC9268415
OpenAlexW4283653318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.